M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas

[1] Louis DN(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820

[2] Perry A(2015)Tumor-associated macrophages in SHH subgroup of medulloblastomas Clinical cancer research : an official journal of the American Association for Cancer Research 21 1457-1465

[3] Reifenberger G(2012)Molecular subgroups of medulloblastoma: the current consensus Acta Neuropathol 123 465-472

[4] von Deimling A(2012)Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas Acta Neuropathol 123 473-484

[5] Figarella-Branger D(2012)Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples Acta Neuropathol 123 615-626

[6] Cavenee WK(2013)Personalizing the treatment of pediatric medulloblastoma: polo-like kinase 1 as a molecular target in high-risk children Cancer Res 73 6734-6744

[7] Ohgaki H(2013)Characterization of distinct immunophenotypes across pediatric brain tumor types J Immunol 191 4880-4888

[8] Wiestler OD(2013)Tumor-associated macrophages in glioma: friend or foe? J. Oncol 2013 486912-24

[9] Kleihues P(2008)Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas J Pathol 216 15-444

[10] Ellison DW(2013)Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients Cancer Sci 104 437-355

[1] Louis DN(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820

[2] Perry A(2015)Tumor-associated macrophages in SHH subgroup of medulloblastomas Clinical cancer research : an official journal of the American Association for Cancer Research 21 1457-1465

[3] Reifenberger G(2012)Molecular subgroups of medulloblastoma: the current consensus Acta Neuropathol 123 465-472

[4] von Deimling A(2012)Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas Acta Neuropathol 123 473-484

[5] Figarella-Branger D(2012)Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples Acta Neuropathol 123 615-626

[6] Cavenee WK(2013)Personalizing the treatment of pediatric medulloblastoma: polo-like kinase 1 as a molecular target in high-risk children Cancer Res 73 6734-6744

[7] Ohgaki H(2013)Characterization of distinct immunophenotypes across pediatric brain tumor types J Immunol 191 4880-4888

[8] Wiestler OD(2013)Tumor-associated macrophages in glioma: friend or foe? J. Oncol 2013 486912-24

[9] Kleihues P(2008)Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas J Pathol 216 15-444

[10] Ellison DW(2013)Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients Cancer Sci 104 437-355